ChatGPT SearchSep 23, 2026
Data as of Oct 18, 2026Based on 315 AI responses from ChatGPT Search and Google AI Mode
Reviewed by Dimitry Apollonsky
AI summary
Investors in the regulated cannabis tech space are typically specialized firms that focus on ancillary services like compliance, data analytics, and supply chain management. If you are seeking funding, top-recommended firms often cited for their deep sector experience include Casa Verde Capital, Poseidon Asset Management, and Phyto Partners. These firms have established portfolios and provide capital across various stages, from seed to growth, specifically targeting technology platforms that help licensed operators scale.
Explore the market rankingCannabis Venture Capital Firms
Brands AI recommends here
Mentioned in · Sep 8 – Sep 23, 2026
ChatGPT SearchSep 23, 2026
Google AI ModeSep 23, 2026
Google AI ModeSep 20, 2026
ChatGPT SearchSep 20, 2026
ChatGPT SearchSep 16, 2026
Google AI ModeSep 16, 2026
Google AI ModeSep 12, 2026
ChatGPT SearchSep 12, 2026
Google AI ModeSep 8, 2026
ChatGPT SearchSep 8, 2026
11% of citations to these sources link to brands' own websites.
businessinsider.com
newcannabisventures.com
startupsavant.com
cannabisbusinesstimes.com
For a regulated cannabis tech company (software, compliance, payments, data, workflow, POS, supply chain, marketplaces, analytics, AI, fintech, etc.), the investor pool is narrower than general SaaS because investors need to understand both venture-scale software and cannabis regulatory complexity. The most relevant funds tend to be cannabis specialists or tech investors with cannabis-adjacent theses.
| Investor | Best fit | Notes |
|---|---|---|
| Casa Verde Capital | B2B software, marketplaces, infrastructure, consumer tech | One of the best-known cannabis venture firms; commonly associated with early-stage and growth investments in cannabis-related technology. |
| Poseidon Asset Management | SaaS, data, compliance, enterprise tools | Longtime cannabis investor with a strong reputation around technology-enabled cannabis businesses. |
| Phyto Partners | Ancillary tech, software, data, services | Often mentioned among the more tech-oriented cannabis funds, especially for early-stage companies. |
| Merida Capital Holdings | Growth-stage infrastructure and tech-enabled services | More growth/infrastructure oriented; relevant if you are beyond early seed. |
| Entourage Effect Capital | Cannabis ecosystem companies | Invests across cannabis categories, including ancillary businesses. |
| Gotham Green Partners | Later-stage cannabis businesses and infrastructure | More growth-oriented but relevant for scaled companies. |
| Navy Capital | Technology, consumer, healthcare, cannabis infrastructure | Sector-focused investor with exposure across cannabis verticals. |
Depending on your product, you may also look beyond cannabis-only funds:
Compliance / regulatory software
Payments / fintech / banking infrastructure
Seed-stage SaaS
Series A/B enterprise software
For regulated cannabis software, the strongest pitches usually emphasize:
If you share your stage (pre-seed/seed/A/B), ARR, geography, and category (POS, compliance, payments, AI, data, marketplace, etc.), I can narrow this to the 10–15 investors most likely to take the meeting.
Navigating venture capital in the regulated cannabis tech space requires looking at two distinct groups of investors: cannabis-focused institutional VCs (who understand the heavy compliance, regulatory, and B2B SaaS landscape of the industry) and generalist/ancillary tech funds that will touch "plant-adjacent" software.
The premier, go-to venture capital firms actively backing and scaling regulated cannabis technology, compliance, and B2B infrastructure include the following key players:
Because cannabis tech is fundamentally enterprise software, fintech, logistics, or data analytics, certain mainstream or flexible generalist tech VCs have historically written checks into the space—particularly for B2B SaaS that doesn't touch the plant:
In the regulated cannabis tech and ancillary space, venture capital behaves a bit differently than traditional tech VC due to ongoing federal restrictions (like 280E tax constraints and banking limitations). The "go-to" investors here are specialized sector-focused funds that deeply understand compliance, seed-to-sale tracking, B2B marketplaces, fintech, and data analytics.
The prominent venture capital and investment firms actively looking at cannabis technology include:
If you’re building regulated cannabis technology—software, compliance, payments, data, POS, supply-chain, workforce, or other ancillary infrastructure—I’d focus on investors with an actual cannabis-tech track record rather than generic VCs that occasionally make a cannabis bet.
| If you're building… | Investors to investigate first |
|---|---|
| Compliance / regulatory infrastructure | Casa Verde, Premo, Poseidon |
| POS / retail software | Casa Verde, Premo, Poseidon |
| Data / analytics | Poseidon, Casa Verde, Phyto, West Creek |
| Payments / fintech | Casa Verde, West Creek, Poseidon |
| Supply-chain / B2B marketplace | Casa Verde, Poseidon |
| Workforce / back-office SaaS | Poseidon, Casa Verde |
There is some useful independent corroboration here: a 2026 investor database currently identifies Poseidon, Casa Verde and Phyto as three of the more active U.S. cannabis investors, with software/SaaS explicitly represented in their investment profiles.
One important distinction: "cannabis VC" isn't necessarily the same thing as "good cannabis-tech VC." For a regulated-tech company, I'd prioritize investors who understand regulatory infrastructure, state-by-state fragmentation, compliance workflows, payments/banking constraints, and enterprise SaaS rather than simply having cannabis brands in their portfolio.
If you tell me what your product does, current ARR/revenue, round size, and whether you're pre-seed/seed/A, I can narrow this to a 10–15 investor target list, including likely check size, relevant portfolio companies, partner to approach, and why your company fits each thesis.
If you’re building regulated cannabis technology—especially B2B SaaS, compliance, payments, data, POS, supply-chain, or infrastructure—the investor universe is meaningfully different from investors focused on cultivation/brands.
| Investor | Why relevant to cannabis tech | Reported stage / focus |
|---|---|---|
| casaverdecapital.com | One of the longest-established cannabis funds; portfolio includes Dutchie, Metrc, LeafLink, Springbig and other technology/infrastructure businesses. | Seed → growth; scalable, capital-efficient businesses |
| poseidonassetmanagement.com | Cannabis specialist since 2013, with an explicit technology + licensed-operator strategy. Particularly relevant to software and infrastructure. | Pre-Series A; U.S.-centric |
| Phyto Partners | Cannabis-focused investor with a substantial software/technology component. | Seed → later-stage; cannabis, software, advertising |
| 7thirty Capital | Specifically oriented toward cannabis-related technology; particularly interesting for infrastructure rather than plant-touching businesses. | Early-stage / growth; cannabis + software |
| Premo Ventures | Worth investigating if you're building cannabis-specific software such as compliance, POS, analytics, ERP or operational infrastructure. | Early-stage |
| Entourage Effect Capital | Larger cannabis investment platform with broader exposure across the ecosystem, including ancillary businesses. | More relevant as you move toward institutional rounds |
| Merida Capital | Cannabis-focused investor with an infrastructure/technology orientation. | Particularly relevant once you're beyond very early seed |
| Gotham Green Partners | Broad cannabis investment platform; potentially relevant for larger institutional financings. | Later-stage / growth-oriented |
As a cross-check, current 2026 investor databases put Poseidon, Casa Verde and Phyto among the most active U.S. cannabis investors, with software/SaaS explicitly represented in their investment profiles.
I wouldn't automatically position the company as a "cannabis company."
If your product is, for example:
you potentially have two investor markets:
Cannabis-native: Casa Verde, Poseidon, Phyto, 7thirty, Premo, Entourage Effect, Merida.
Technology/generalist: VCs investing in vertical SaaS, fintech, regtech, enterprise software, etc., where cannabis is initially your beachhead market.
That second group can be particularly valuable if the technology could eventually serve other highly regulated industries. Casa Verde's own portfolio, for example, includes regulatory compliance, banking/payments compliance, insurance/risk management, analytics, POS and inventory technology—not just cannabis brands.
Give me these five things:
I can then narrow this to 15–25 specific funds, with their relevant portfolio companies, approximate check/stage fit, and the specific partner/team member I'd target at each.
Navigating the regulated cannabis tech space requires investors who not only understand software, hardware, or biotech, but also know how to navigate complex state-by-state compliance, banking restrictions, and shifting federal regulations.
The prominent venture capital and private equity firms focusing heavily on or actively investing in the cannabis technology and ancillary ecosystem include:
Because mainstream generalist VCs (like Sequoia or a16z) have historically blown hot and cold on the sector due to federal rescheduling delays and compliance barriers, leaning into dedicated cannabis-ancillary funds like Casa Verde or Merida often yields partners who already have the regulatory framework internalized—meaning less time spent educating them on why your B2B software is legal and scalable.
Navigating the regulated cannabis tech space means looking for investors who understand not just software and infrastructure, but the labyrinth of state-by-state compliance, seed-to-sale tracking, and the unique risk profile of the industry.
The go-to venture capital firms and dedicated funds that specialize in or actively back cannabis tech, ancillary infrastructure, and compliance-driven software include:
Mainstream generalist VCs (outside of specialized funds like Casa Verde or specific angel syndicates) can still be gun-shy about "cannabis" due to legacy LP restrictions—even if your product is purely software and "non-plant-touching."
If you encounter hesitation from traditional tech VCs, lean hard into your B2B SaaS metrics, regulatory compliance moat, and enterprise infrastructure angle rather than the word "cannabis" itself. Positioning your company as a high-margin data, workflow, or fintech platform that happens to serve a hyper-growth, highly regulated market usually gets past the compliance filters of broader tech funds.
If you’re in regulated cannabis tech—especially B2B SaaS, compliance, payments, POS, data, supply chain, or infrastructure—I’d prioritize cannabis-specialist VCs that understand the regulatory mess and mainstream software investors that have already proven they’ll touch the category.
For cannabis tech rather than cannabis cultivation/brands, I'd also pursue conventional software investors that have already demonstrated willingness to invest in the sector.
The best proof point is Dutchie: its financing included Thrive Capital, Tiger Global, D1 Capital, Dragoneer and DFJ Growth, alongside cannabis specialists such as Casa Verde and Gron.
And BLAZE, another cannabis software platform, raised its Series A from Delta Emerald Ventures, Act One Ventures and SOJE Capital; Act One specifically cited its experience with compliance and vertical SaaS.
That distinction matters: a VC that understands SaaS + regulated markets can sometimes be more valuable than a generic "cannabis VC."
| If you're building… | Investors I'd start with |
|---|---|
| Compliance / regulatory tech | Poseidon, Casa Verde, Phyto, Act One |
| POS / ERP / dispensary software | Casa Verde, Poseidon, Gron, Delta Emerald |
| Payments / fintech | Casa Verde + fintech VCs willing to enter cannabis |
| Supply chain / seed-to-sale | Poseidon, Merida, Phyto |
| Data / analytics / AI | Poseidon, Casa Verde + mainstream SaaS/AI funds |
| B2B marketplace / commerce |
One important caveat: the cannabis-capital market has changed substantially from the 2020–22 boom. I would not interpret an old cannabis portfolio or a historical check as evidence that a fund is currently deploying aggressively. Current industry databases still put Casa Verde, Poseidon and Phyto among the most active investors, but I'd verify each fund's current mandate before spending time on an outreach.
If you tell me what your product actually does, your stage (pre-seed/seed/A/B), amount you're raising, and whether you're plant-touching or ancillary, I can narrow this to 10–15 specific funds, likely check sizes, relevant portfolio companies, partners to approach, and the best outreach order.
The premier venture capital and investment firms specializing in regulated cannabis technology and ancillary services include Casa Verde Capital, Merida Capital Holdings , and Entourage Effect Capital. [](https://shizune.co/investors/cannabis-investors-united-states)
Because federal regulations limit direct "plant-touching" investments for many traditional funds, the cannabis tech and B2B SaaS sectors (compliance tracking, point-of-sale, data platforms, and supply chain logistics) are primary targets for specialized ancillary-focused VCs.
For a regulated cannabis tech company (especially B2B SaaS, compliance, payments, data, marketplaces, POS, supply chain, ERP, analytics, or infrastructure), the best investors are usually cannabis-specialist VCs plus a small number of tech VCs comfortable with regulated markets. The firms below are the ones founders most often target for this category.
Look especially at:
Consider:
You may be able to broaden beyond cannabis-only funds:
The pitch is usually stronger when framed as “regulated-industry infrastructure” rather than simply “cannabis.” Investors tend to care about:
If I were building a first-pass outreach list for a cannabis software company, I would probably start with:
Then add non-cannabis SaaS/vertical-market VCs once you have enough traction to show the company is a software business first.
If you share your stage (pre-seed/seed/A/B), ARR, product category (POS, compliance, payments, AI, marketplace, etc.), and whether you touch the plant or are ancillary, I can narrow this to a more realistic 15–25 investor list with likely check sizes and partner names.
| Pre-seed / seed | Arcview, Poseidon, Phyto, Premo |
| Series A+ | Casa Verde, Entourage Effect, Poseidon |
| Casa Verde, Gron + mainstream marketplace VCs |
| Growth-stage infrastructure | Entourage Effect, Merida, Gotham Green |
| Consumer-facing cannabis tech | Casa Verde, Gron, Phyto + consumer-tech VCs |